Risk of p53 gene mutation in esophageal squamous cell carcinoma and habit of betel quid chewing in Taiwanese

Cancer Science

Volumn 96, Issue 11, 2005, Pages 758-765

  Goan, Yih Gang ^a,b,c   Chang, Huang Chou ^a   Hsu, Hon Ki ^a   Chou, Yi Pin ^a   Cheng, Jiin Tsuey ^c  

^a KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

PARAFFIN; PROTEIN P53; RNA;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BETEL NUT; CANCER INCIDENCE; CANCER RISK; CARCINOGENESIS; CIGARETTE SMOKING; CORRELATION ANALYSIS; DISEASE ASSOCIATION; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS RESECTION; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENE MUTATION; GENE SEQUENCE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; NUCLEIC ACID BASE SUBSTITUTION; PRIORITY JOURNAL; PROTEIN TARGETING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK ASSESSMENT; RISK FACTOR; RNA EXTRACTION; SEQUENCE ANALYSIS; TAIWAN; TUMOR SUPPRESSOR GENE;

ADULT; AGED; AGED, 80 AND OVER; ARECA; CARCINOGENS; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; DNA MUTATIONAL ANALYSIS; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; GENES, P53; HUMANS; INCIDENCE; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; RISK FACTORS; TAIWAN;

EID: 29644447621     PISSN: 13479032     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2005.00115.x     Document Type: Article

References (50)

1. American Cancer Society. Cancer Facts and Figures 2004. Atlanta: American Cancer Society, 2004.
2. Flood WA, Furastiere AA. Esophageal cancer. Curr Opin Onco 1995; 7: 381-6.
3. Blot WJ. Esophageal cancer trends and risk factors. Semin Oncol 1994; 121: 403-10.
4. Department of Health, Executive Yuan, Republic of China. Health Statistics. Vol. II. Vital statistics: 1972-2002. Taipei: Department of Health, Executive Yuan, Taiwan, 2003.
5. Wu MT, Lee YC, Chen CJ et al. Risk of betel chewing for esophageal cancer in Taiwan. Br J Cancer 2001; 85: 658-60.
6. Lee CH, Lee JM, Wu DC et al. Independent and combined effect of alcohol intake, tobacco smoking and BQ chewing on the risk of esophageal cancer in Taiwan. Int J Cancer 2005; 113: 475-82.
7. Phukan RK, Ali MS, Chetia CK et al. Betel nut and tobacco chewing; potential risk factors of cancer of esophagus in Assam, India. Br J Cancer 2001; 85: 661-7.
8. Boonyaphiphat P, Thongsuksai P, Sriplung H et al. Lifestyle habits and genetic susceptibility and the risk of esophageal cancer in the Thai population. Cancer Lett 2002; 186: 193-9.
9. Lee JM, Lee YC, Yang SY et al. Genetic polymorphisms of p53 and GSPT1, but not NAT2, are associated with susceptibility to squamous cell carcinoma of the esophagus. Int J Cancer 2000; 89: 458-64.
10. Sankaranarayanan R, Duffy SW, Padmakumary G et al. Risk factors for cancer of the oesophagus in Kerala, India. Int J Cancer 1991; 49: 485-9.
11. Hu N, Huang J, Emmert-Buck MR et al. Frequent inactivation of the TP53 gene in ESCC from high-risk population in China. Clin Cancer Res 2001; 7: 883-91.
12. Hollstein M, Sidransky D, Vogelstein B et al. P53 mutation in human cancer. Science 1991; 253: 49-53.
13. Havrilesky L, Darcy KM, Hamdan K et al. Prognostic significance of p53 mutation and p53 overexpression in advanced epithelial ovarian cancer: a gynecologic oncology group study. J Clin Oncol 2003; 21: 3814-25.
14. Nigro JM, Baker SJ, Preisinger AC et al. Mutations in the p53 gene occurs in diverse human tumor types. Nature 1989; 342: 704-8.
15. Taniere P, Martel-Planche G, Puttawibul P et al. TP53 mutations and MDM2 gene amplification in squamous-cell carcinomas of the esophagus in south Thailand. Int J Cancer 2000; 88: 223-7.
16. Suwiwat S, Oda H, Shimizu Y et al. Prevalence of p53 mutations and protein expression in esophageal cancer in southern Thailand. Int J Cancer 1997; 72: 23-6.
17. Putz A, Hartmann AA, Fontes PRO et al. Tp53 mutation pattern of ESCC in a high risk area (Southern Brazil): Role of lifestyle factors. Int J Cancer 2002; 98: 99-105.
18. Robert V, Michel P, Flaman JM et al. High frequency in esophageal cancers of p53 alterations inactivating the regulation of genes involved in cell cycle and apoptosis. Carcinogenesis 2000; 21: 563-5.
19. King RJB. Cancer biology. In: Chemical and Radiation Carcinogenesis, Predicting the Type of Carcinogen by Mutational Spectrum Analysis. Harlow, Essex, UK: Pearson Education Limited, 2000; 117-9.
20. Greenblatt MS, Bennett WP, Harris CC. Mutations in the p53 tumor suppressor gene: Clues to cancer etiology and molecular pathogenesis. Cancer Res 1994; 54: 4855-78.
21. Hollstein M, Peri L, Mandard AM et al. Genetic analysis of human esophageal tumors from two high incidence geographic areas: Frequent p53 base substitutions and absence of ras mutations. Cancer Res 1991; 51: 4102-6.
22. Hsieh LL, Wang PF, Chen IH et al. Characteristics of mutations in the p53 gene in oral squamous cell carcinoma associated with BQ chewing and cigarette smoking in Taiwanese. Carcinogenesis 2001; 22: 1497-503.
23. Chiba I. Prevention of BQ chewers' oral cancers in the Asian-Pacific area. Asian Pacific J Cancer Prev 2001; 2: 263-9.
24. Rozemuller EH, Kropveld A, Kreyveld E et al. Sensitive detection of p53 mutation: Analysis by direct sequencing and multisequence analysis. Cancer Detect Prev 2001; 25: 109-16.
25. Lee SN, Park CK, Sung CO et al. Correlation of mutation and immunohistochemistry of p53 in hepatocellular carcinomas in Korean people. J Korean Med Sci 2002; 17: 801-5.
26. Lane DP. P53, guardian of the genome. Nature 1992; 358: 15-6.
27. Levine AJ. P53, the cellular gatekeeper for growth and division. Cell 1997; 88: 323-31.
28. Sheu JC, Huang GT, Lee PH et al. Mutation of p53 gene in hepatocellular carcinoma in Taiwan. Cancer Res 1992; 52: 6098-100.
29. Shi ST, Yang GY, Wang LD et al. Role of p53 gene mutations in human esophageal carcinogenesis: Results from immunohistochemical and mutation analyses of carcinomas and nearby non-cancerous lesions. Carcinogenesis 1999; 20: 591-7.
30. Biramijamal F, Allameh A, Mirbod P et al. Unusual profile and high prevalence of p53 mutations in ESCCs from northern Iran. Cancer Res 2001; 61: 3119-23.
31. Ralhan R, Arora S, Chattopadhyay TK et al. Circulating p53 antibodies, p53 gene mutational profile and product accumulation in esophageal squamous-cell carcinoma in India. Int J Cancer 2000; 85: 791-5.
32. Montesano R, Hollstein M, Hainaut P. Genetic alterations in esophageal cancer and their relevance to etiology and pathogenesis; a review. Int J Cancer 1996; 69: 225-35.
33. Lazarus P, Stem J, Zwiebel N et al. Relationship between p53 mutation incidence in oral cavity squamous cell carcinomas and patient tobacco use. Carcinogenesis 1996; 17: 733-9.
34. Brennan JA, Boyle JO, Koch WM et al. Association between cigarette smoking and mutation of the p53 gene in squamous cell carcinoma of the head and neck. New Engl J Med 1995; 232: 712-7.
35. Olivier M, Eeles R, Hollstein M et al. The IARC TP53 database: new online mutation analysis and recommendations to users. Hum Mutat 2002; 19: 607-14.
36. Wiencke JK. Impact of race/ethnicity on molecular pathways in human cancer. Nat Rev Cancer 2004; 4: 79-84.
37. Hainaut P, Hernandez T, Robinson A et al. IARC database of p53 gene mutations in human tumors and cell lines: Updated compilation, revised formats and new visualization tools. Nucleic Acids Res 1998; 26: 205-13.
38. Bartsch H, Rojas MN, Alexandrov K. Impact of adduct determination on the assessment of cancer susceptibility. Rec Res Cancer Res 1998; 154: 86-96.
39. Audrezet M, Robaszkeiwicz M, Mercier B et al. TP53 gene mutation profile in ESCCs. Cancer Res 1993; 53: 5745-9.
40. Mir MM, Dar NA, Gochhait S et al. p53 mutation profile of squamous cell carcinomas of the esophagus in Kashmir (India): A high-incidence area. Int J Cancer 2005; 116: 62-8.
41. International Agency for Research on Cancer. Monograph I. Evaluation of the Carcinogenic Risk of Chemicals to Human. Tobacco Habits other than Smoking; Betel-quid and Areca Nut Chewing; and some Related Nitrosamines. Vol. 37. Lyon, France: International Agency for Research on Cancer, 1985.
42. Hoffmann D, Brunnemann KD, Prolopczyk B et al. Tobacco-specific N-nitrosamines and Areca-derived N-nitrosamine: Chemistry, biochemistry, carcinogenicity and relevance to humans. J Toxicol Env Health 1994; 41: 1-52.
43. Sundquist K, Lie Y, Erhardt P. Areca-nut toxicity in cultured human buccal epithelial cell. IARC Sci Publ 1991; 105: 281-5.
44. Wary KK, Sharan RN. Cytotoxic and cytostatic, effects of arecoline and sodium nitrite on human cells in vitro. Int J Cancer 1991; 47: 396-400.
45. Kamiya H, Kasai H. Substitution and deletion mutations induced by 2-hydroxyadenine in Escherichia coli: Effects of sequence contexts in leading and lagging strands. Nucleic Acids Res 1997; 15: 304-11.
46. Nguyen T, Brunson D, Crespi CL et al. DNA damage and mutation in human cells exposed to nitric oxide in vitro. Proc Nat Acad Sci USA 1992; 89: 3030-4.
47. Karran P, Lindahl T. Hypoxanthine in deoxyribonucleic acid: Generation by heat-induced hydrolysis of adenine residues and release in free form by a deoxyribonucleic acid glycosylase from calf thymus. Biochemistry 1980; 23: 6005-11.
48. Nair UJ, Friesen M, Richard I. Effect of lime composition on the formation of reactive oxygen species from areca nut extract in vitro. Carcinogenesis 1990; 11: 2145-8.
49. Lee JM, Liu TY, Wu DC et al. Safrole-DNA adducts in tissues from esophageal caner patients: Clues to areca-related esophageal carcinogenesis. Mutation Res 2005; 565: 121-8.
50. Chen CL, Chi CW, Chang KW et al. Safrole-like DNA adducts in oral tissue from oral cancer patients with a BQ chewing history. Carcinogenesis 1999; 20: 2331-4.